Labcorp (NYSE: LH) revenue
Labcorp reported revenue of $13,952m for fiscal 2025, 7.2% more than in fiscal 2024 ($13,009m). Since fiscal 2016 its revenue has grown by 46.0%, an average growth of 4.3% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $13,952m | +7.2% | $1,385m | 9.9% |
| 2024 | $13,009m | +7.0% | $1,087m | 8.4% |
| 2023 | $12,162m | +2.5% | $725.6m | 6.0% |
| 2022 | $11,864m | −9.7% | $1,437m | 12.1% |
| 2021 | $13,136m | −6.0% | $3,049m | 23.2% |
| 2020 | $13,979m | +21.0% | $2,445m | 17.5% |
| 2019 | $11,555m | +2.0% | $1,330m | 11.5% |
| 2018 | $11,333m | +9.9% | $1,326m | 11.7% |
| 2017 | $10,308m | +7.9% | $1,305m | 12.7% |
| 2016 | $9,553m | — | $1,271m | 13.3% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the revenue of Labcorp
- How much revenue did Labcorp make in fiscal 2025?
- Labcorp reported revenue of $13,952m for fiscal 2025, compared with $13,009m in fiscal 2024.
- How much has the revenue of Labcorp grown?
- Between fiscal 2016 and fiscal 2025 it went from $9,553m to $13,952m: 46.0% more, an average growth of 4.3% a year.
- What was the best year for revenue at Labcorp?
- Of its last 10 fiscal years, fiscal 2020, with $13,979m.
- Where do the figures for Labcorp come from?
- From the annual report (Form 10-K) that Labcorp files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Labcorp files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Labcorp: the Labcorp page · annual accounts · net income · dividends paid · insider transactions.
Dividend per share of Labcorp by fiscal year, with the filing behind every figure: Labcorp dividend history.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.